Works matching IS 09650407 AND DT 2023 AND VI 31 AND IP 3
Results: 14
Transcriptome analysis reveals tumor antigen and immune subtypes of melanoma.
- Published in:
- Oncology Research, 2023, v. 31, n. 3, p. 389, doi. 10.32604/or.2023.029274
- By:
- Publication type:
- Article
The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway.
- Published in:
- Oncology Research, 2023, v. 31, n. 3, p. 375, doi. 10.32604/or.2023.028256
- By:
- Publication type:
- Article
Senescent mesenchymal stem/stromal cells in pre-metastatic bone marrow of untreated advanced breast cancer patients.
- Published in:
- Oncology Research, 2023, v. 31, n. 3, p. 361, doi. 10.32604/or.2023.028104
- By:
- Publication type:
- Article
Mechanism of NURP1 in temozolomide resistance in hypoxia-treated glioma cells via the KDM3A/TFEB axis.
- Published in:
- Oncology Research, 2023, v. 31, n. 3, p. 345, doi. 10.32604/or.2023.028724
- By:
- Publication type:
- Article
Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways.
- Published in:
- Oncology Research, 2023, v. 31, n. 3, p. 333, doi. 10.32604/or.2023.028694
- By:
- Publication type:
- Article
Calcyclin-binding protein contributes to cholangiocarcinoma progression by inhibiting ubiquitination of MCM2.
- Published in:
- Oncology Research, 2023, v. 31, n. 3, p. 317, doi. 10.32604/or.2023.028418
- By:
- Publication type:
- Article
The zinc figure protein ZNF575 impairs colorectal cancer growth via promoting p53 transcription.
- Published in:
- Oncology Research, 2023, v. 31, n. 3, p. 307, doi. 10.32604/or.2023.028564
- By:
- Publication type:
- Article
Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study.
- Published in:
- Oncology Research, 2023, v. 31, n. 3, p. 299, doi. 10.32604/or.2023.028840
- By:
- Publication type:
- Article
Apolipoprotein C1 promotes tumor progression in gastric cancer.
- Published in:
- Oncology Research, 2023, v. 31, n. 3, p. 287, doi. 10.32604/or.2023.028124
- By:
- Publication type:
- Article
High expression of PD-L1 mainly occurs in non-small cell lung cancer patients with squamous cell carcinoma or poor differentiation.
- Published in:
- Oncology Research, 2023, v. 31, n. 3, p. 275, doi. 10.32604/or.2023.028227
- By:
- Publication type:
- Article
Liquid biopsy and blood-based minimal residual disease evaluation in multiple myeloma.
- Published in:
- Oncology Research, 2023, v. 31, n. 3, p. 271, doi. 10.32604/or.2023.028668
- By:
- Publication type:
- Article
Review and prospect of immune checkpoint blockade therapy represented by PD-1/PD-L1 in the treatment of clear cell renal cell carcinoma.
- Published in:
- Oncology Research, 2023, v. 31, n. 3, p. 255, doi. 10.32604/or.2023.027942
- By:
- Publication type:
- Article
PPARα activator irbesartan suppresses the proliferation of endometrial carcinoma cells via SREBP1 and ARID1A.
- Published in:
- Oncology Research, 2023, v. 31, n. 3, p. 239, doi. 10.32604/or.2023.026067
- By:
- Publication type:
- Article
Targeting triple-negative breast cancer: A clinical perspective.
- Published in:
- Oncology Research, 2023, v. 31, n. 3, p. 221, doi. 10.32604/or.2023.028525
- By:
- Publication type:
- Article